As previously mentioned, high intakes of NAC in healthy individuals may have pro-oxidant effects [107109], and both oral [110] and systemically administered [83] NAC can be poorly tolerated
#Cardiometabolic #patients #GLP-1 Hanson Wade Peter Gannon is heading to Boston this week for the GLP-1 Based Therapeutics Summit (April 1416)
We then create a customized approach based on this information
For weight management, semaglutide is FDA-approved under the brand name Wegovy rather than Ozempic
LY3437943, a Novel Triple Glucagon, GIP, and GLP-1 Receptor Agonist for Glycemic Control and Weight Loss: From Discovery to Clinical Proof of Concept, Coskun T
This approach improves outcomes from multiple angles rather than adding new risks